Artia Global Partners LP

Source: SEC Form 13F · as of Mar 2026

Artia Global Partners LP holds 43 biotech & pharma companies tracked by BioSniper, totaling $477.5M in value as of Mar 2026 (SEC Form 13F).

Companies held

43

Total value held

$477.5M

CompanySharesValue
INSMINSMED Inc908,412$148.5M
ABVXAbivax SA600,747$66.9M
LLYELI LILLY & Co38,220$35.2M
TRVITrevi Therapeutics, Inc.2,013,602$24.0M
ARGXARGENX SE29,739$21.7M
AZNASTRAZENECA PLC95,376$18.8M
NAMSNEWAMSTERDAM PHARMA CO N.V.503,936$16.1M
DNTHDianthus Therapeutics, Inc. /DE/162,990$13.7M
RVMDREVOLUTION MEDICINES, INC.124,990$12.2M
IONSIONIS PHARMACEUTICALS INC144,376$10.8M
MRNAModerna, Inc.200,000$10.2M
DGXQuest Diagnostics Incorporated40,817$8.0M
ALMSALUMIS INC.325,046$7.2M
VKTXViking Therapeutics, Inc.180,731$5.9M
MRKMerck & Co., Inc.46,700$5.6M
TERNTerns Pharmaceuticals, Inc.104,800$5.5M
JNJJOHNSON & JOHNSON22,600$5.5M
SIONSionna Therapeutics, Inc.119,741$4.8M
SRRKScholar Rock Holding Corp96,285$4.7M
RAPPRapport Therapeutics, Inc.138,508$4.3M
BLTEBELITE BIO, INC24,989$4.0M
XENEXenon Pharmaceuticals Inc.65,000$3.8M
MLYSMineralys Therapeutics, Inc.137,800$3.7M
ROIVRoivant Sciences Ltd.129,800$3.6M
PALIPALISADE BIO, INC.1,992,367$3.5M
BIIBBIOGEN INC.18,437$3.4M
ABBVAbbVie Inc.14,500$3.2M
UTHRUNITED THERAPEUTICS Corp5,000$3.0M
DRUGBRIGHT MINDS BIOSCIENCES INC.38,407$2.8M
PTGXProtagonist Therapeutics, Inc22,931$2.4M
SLNOSOLENO THERAPEUTICS INC68,490$2.3M
TVTXTravere Therapeutics, Inc.70,700$2.1M
EWTXEdgewise Therapeutics, Inc.65,500$2.1M
BBIOBridgeBio Pharma, Inc.20,400$1.5M
KNSAKiniksa Pharmaceuticals International, plc29,200$1.4M
CYTKCYTOKINETICS INC16,300$1.1M
ELVNEnliven Therapeutics, Inc.20,900$819K
PRAXPraxis Precision Medicines, Inc.2,500$805K
KODKodiak Sciences Inc.17,019$649K
NUVLNuvalent, Inc.4,900$502K
APGEApogee Therapeutics, Inc.5,886$495K
AVTXAvalo Therapeutics, Inc.28,970$433K
PEPGPepGen Inc.205,324$363K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Artia Global Partners LP — Biotech 13F Holdings & Portfolio | BioSniper